LY518674 is a potent, selective PPARalpha agonist, with an EC50 of 42 nM for human PPARalpha. LY518674 reduces triglycerides in and increased HDL-C and is used for the treatment of atherosclerosis[1][2][3].
Molecular Weight:
409.48
Purity:
98.75
CAS Number:
[425671-29-0]
Formula:
C23H27N3O4
Target:
PPAR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted